The Non-Steroids Antiinflammatory and Antirheumatic Medicine market in Germany showed modest growth from 2024 to 2028. In 2023, the market stood at approximately 502.6 million Euros. The forecasted data from 2024 to 2028 indicates a steady increase, with compound annual growth rate (CAGR) reflecting a gradual uptrend. Year-on-year growth was consistent but minimal, indicating a stable market demand during this period.

Future trends to watch for include:

Emergence of new medications or formulations that could drive market expansion.
Increasing emphasis on biologics or advanced therapies potentially influencing market dynamics.
Regulatory changes affecting drug pricing and market access.
Demographic shifts leading to higher demand as the population ages.